Medicilon IncMedicilon IncMedicilon IncMedicilon Inc
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact

Generics Consistency Evaluation

Home Service Generics Consistency Evaluation

Generic Medicine Evaluation of Consistency Quality Services

  • Quality Comparison of the Preparations and Generic Drugs
  • Prescription Technology Redevelopment Services
  • Animal BE Service

Medicilon Provide Generic Drug Quality Consistency Workflow

  • Determine the Reference Formulation
  • Method of Determining Key Indicators
  • Comprehensive Comparison between Reference and Generic Drugs
  • Re-development of Prescription and Manufacture Process
  • Pilot Production Scale Up, Production Technology Transfer
  • Animal BE Services (Optional)
  • Data Collation
Contact Us

Share

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

  • Medicilon's Formulation
  • Medicilon Formulation
  • Medicilon Formulation Lab
  • Medicilon Formulation Equipment
  • Medicilon Drug Formulation
  • Formulation
  • Formulation Medicilon

You May Also Like

  • Integrated Projects

    Integrated Projects

    Integrated Projects

  • Drug Safety Evaluation

    Drug Safety Evaluation

    Drug Safety Evaluation

  • Bioanalytical Services

    Bioanalytical Services

    Bioanalytical Services

  • Pharmacokinetic Services

    Pharmacokinetic Services

    Pharmacokinetic Services

  • Pharmacology Services

    Pharmacology Services

    Pharmacology Services

  • Biology Services

    Biology Services

    Biology Services

  • Drug Formulation

    Drug Formulation

    Drug Formulation

  • Chemistry Services

    Chemistry Services

    chemistry

    Chemistry Services

    chemistry

Recent News

  • Happy Chinese New Year

    Thank you for your business, support and partnership in 2020!  Medicilon appreciates working with you and

    Read More
  • 3D Med

    3D011-08 from 3D Medicines was approved of conducting clinical trials

    Jan 29th, 2021 – CDE announced that the innovative drug, 3D011-08 from 3D Medicines, was approved

    Read More
  • Xuanzhu Biotech

    Xuanzhu Biotech Announced the Clinical Trial Approval of XZP-5610

    Jan.27, 2021 – Xuanzhu Biotech announced that their XZP-5610, a new treatment for NASH (non-alcoholic steatohepatitis),

    Read More
  • Medicilon was Awarded the Excellent Academician and Expert Workstation of Shanghai and Pudong New Area

    Recently, Shanghai Medicilon was awarded the title of “Excellent Expert Workstation” by the Shanghai Academician and

    Read More
  • Medicilon’s Top 10 Greatest Achievements in 2020

    You may say that the Coronavirus Pandemic will define 2020. You may say that 2020 has

    Read More
  • Medicilon's pharmacology models for inflammatory-immune diseases

    Medicilon’s pharmacology models for inflammatory-immune diseases

    Inflammatory immune diseases have gained much attention as the incidence has grown bigger each year. The

    Read More
  • Medicilon is Listed as the 2020 TOP10 Innovation CRO in China

    Dec.20, 2020, Hebei—The 13th China Pharmaceutical Strategy Conference 2020 was held successfully. The conference presented the

    Read More
  • Medicilon's CDMO Services Platform

    Medicilon’s CDMO Service Platform

    Medicilon has constructed the GMP Drug Products Pilot Plant to meet the rising needs for innovative

    Read More

Interested in our expertise?

Let's Start the Conversation

Contact Us

About Us

  • Medicilon Overview
  • Executive Team
  • CEO Message
  • Company History
  • Corporate Culture
  • Honor

Services

  • Chemistry
  • Biology
  • Bioanalytical
  • Drug Safety Evaluation
  • Formulation Development
  • Pharmacology
  • Pharmacokinetic
  • Integrated Projects

Customer Center

  • Customer Reviews
  • Download Center
  • Intellectual Property Protection
  • New Models of Collaboration

Contact Us

Shanghai Medicilon Inc.

Address: No. 585, Chuanda Road, Pudong, Shanghai, 201200, China
Email: Marketing@medicilon.com
Website: www.medicilon.com

Copyright 2017 Shanghai Medicilon inc. | All Rights Reserved Privacy Policy
  • Languages
  • 中国日本대한민국
  • Home
  • About
    • Medicilon Overview
    • Executive Team
    • CEO Message
    • Corporate Culture
    • Company History
    • Honor
  • Services
    • Integrated Projects
      • Antibody-Drug-Antibody (ADC)
      • Preclinical Research Services
      • IND Filing
      • Bio Drug Development
      • Chemical Drug Development
      • Chemical Compound Druggability Assessment
      • Molecular Imaging & Radiochemistry
      • OINDP Development
      • Preclinical Ophthalmic Research Platform
    • Pharmacology Services
      • Cancer Xenograft Models
      • Orthotopic Models
      • Syngeneic Mouse Models
      • Transgenic Mouse Model
      • Humanized Mouse Model (hPBMCEngrafted)
      • PDX Model
      • Digestive System Models
      • Neurological Disorders Models
      • Metabolic Disease Models
      • Inflammation & Immunological Disease Models
      • Other Disease Models
    • Chemistry Services
      • Medicinal Chemistry Services
      • Synthetic Chemistry
      • Process Development Services
      • Analytical Chemistry
    • Drug Formulation
      • Pre Formulation Development
      • Analytical Development
      • Formulation Development Services
      • Generics Consistency Evaluation
      • Research on Quality Control
      • Clinical Trial Material
      • OINDP Development
    • Biology Services
      • Discovery Biology Services
      • Recombinant Protein Services
      • Computational Biology & Molecular Modeling
      • Crystallization & Structural Determination
      • Kinase Services
      • SeMet Media Sales
    • Bioanalytical Services
      • Large Molecule Bioanalysis
      • Small Molecule Bioanalysis
    • Pharmacokinetic Services
      • In Vivo Assays
      • In Vitro Assays
    • Drug Safety Evaluation
      • Inhalation Toxicity Assessment
  • Customer
    • Customer Reviews
    • New Models of Collaboration
    • Intellectual Property Protection
    • Download Center
  • Careers
  • News
    • Medicilon Events
    • Media Coverage
    • Featured Stories
  • Contact
Medicilon Inc